Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyzed Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109851598B details a robust ruthenium-catalyzed route for trifluoromethyl enol esters, offering superior regioselectivity and cost efficiency for pharmaceutical manufacturing.
Patent CN107522645B details a novel ruthenium-catalyzed [3+2] cycloaddition for polysubstituted pyrroles. This method offers mild conditions and broad substrate scope for pharmaceutical intermediates.
Solve multi-step synthesis challenges for pyrrole intermediates. 50-71% yields, mild conditions, and broad substrate scope. Scale to 100 MT/yr.
Discover how ruthenium-catalyzed 3+2 cycloaddition enables efficient, single-step pyrrole synthesis with 50-71% yields, reducing multi-step costs and supply chain risks for pharmaceutical intermediates.